Has Nicholas Boulis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $43,608 in general payments to Nicholas Boulis, MD across 150 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Boulis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Boulis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Boulis, MD

Neurological Surgery · Atlanta, GANPI 1164485041

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,950 of the $43,608 with a category attached, or 73.3%. 17 manufacturers reported payments, led by UCB SA at 59.2% of the total. Reporting peaked in 2021 at $17,613 and has fallen 72.4% since, to $4,859 in 2025.

$43,608in general payments, 2019–2025

Across 150 payments — averaging $290.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB SA$26K
PTC Therapeutics, Inc.$5K
Clearpoint Neuro, Inc.$3K
Medtronic$3K
Abbott$2K
Biotronik NRO, Inc.$2K
plus $4K from 11 others

$40,695in research payments, 2019–2025

Across 4 payments — averaging $10,174 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

PTC Therapeutics, Inc.$29K
Medtronic$11K

What the payments were for

Consulting fees$31,95073%
Travel & lodging$4,51510%
Food & beverage$7,14416%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB SA	7	$25,800
PTC Therapeutics, Inc.	4	$4,612
Clearpoint Neuro, Inc.	14	$2,777
Medtronic(2 entities)	28	$2,573
Abbott	50	$2,392
Biotronik NRO, Inc.	17	$1,927
Boston Scientific	12	$1,919
Microtransponder, Inc.	2	$457
Nevro Corp.	3	$283
Nalu Medical, Inc.	2	$212
Axogen	3	$179
Neuropace, Inc.	1	$132
Camber Spine Technologies LLC	2	$131
Saluda Medical Americas, Inc.	1	$80
Lilly USA, LLC	2	$65
Bioventus LLC	1	$46
Biotronik Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,608 in reported general payments places this provider in the 80th percentile of 201 neurological surgery providers in Georgia.

See all neurological surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$125,215

Medicare patients

147

Services billed

299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	17	$603
Ondansetron OdtOndansetron	54	$396
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	55	$353
Chlorthalidone	12	$55
Ondansetron Hcl	11	$35

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Atlanta

Regis HaidAtlanta$25.5M
Thomas MorrisonAtlanta$2.8M
Christopher TomarasAtlanta$1.5M
Daniel RefaiAtlanta$1.2M
Gerald RodtsAtlanta$1.2M
James RobinsonAtlanta$993K
Michele JohnsonAtlanta$540K
David McCrackenAtlanta$425K
Robert GrossAtlanta$315K
Kaveh KhajaviAtlanta$225K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →